<DOC>
	<DOC>NCT00174291</DOC>
	<brief_summary>- To evaluate the effect of increasing the growth hormone dose on the statural response - To assess the value of early treatment during the course of arthritic disease by comparing the height acquired in the medium term by children in the two groups: treated from the start, or 1 year to 15 months after the diagnosis of CJA, or treated for 4 years after the diagnosis</brief_summary>
	<brief_title>Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy</brief_title>
	<detailed_description>This trial terminated on 10-Jun-2011 due to prolonged issues with drug accountability and data collection discrepancies. The decision to terminate was not based on any safety concerns.</detailed_description>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<criteria>This study will be proposed to all patients previously included in study CTN 978129016 Discontinuation of corticosteroid therapy for more than a year during study CTN 978129016 Patients withdrawing from the study prematurely</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>